%D8%A7%D9%86%D8%AD%D9%84%D8%A7%D9%84_%D8%A7%D9%84%D8%AE%D8%AB%D8%B1%D8%A9%D0%A2%D1%80%D0%B0%D0%BC%D0%B1%D0%B0%D0%BB%D1%96%D1%82%D1%8B%D1%87%D0%BD%D0%B0%D1%8F_%D1%82%D1%8D%D1%80%D0%B0%D0%BF%D1%96%D1%8FTromb%C3%B2lisiTrombolyseThrombolyseThrombolysisAntitromb%C3%B3ticoThrombolyseTrombolisiTrombolyseTrombolyseTromboliza%D0%A2%D1%80%D0%BE%D0%BC%D0%B1%D0%BE%D0%BB%D0%B8%D1%82%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B0%D1%8F_%D1%82%D0%B5%D1%80%D0%B0%D0%BF%D0%B8%D1%8FTrombolys%D0%A2%D1%80%D0%BE%D0%BC%D0%B1%D0%BE%D0%BB%D1%96%D1%82%D0%B8%D1%87%D0%BD%D0%B0_%D1%82%D0%B5%D1%80%D0%B0%D0%BF%D1%96%D1%8FTan_huy%E1%BA%BFt_kh%E1%BB%91iQ1931577
about
P279
Dutch randomized trial comparing standard catheter-directed thrombolysis versus ultrasound-accelerated thrombolysis for thromboembolic infrainguinal disease (DUET): design and rationalePre-hospital versus in-hospital thrombolysis for ST-elevation myocardial infarctionMortality of stroke patients treated with thrombolysis: Analysis of nationwide inpatient sampleThrombolysis in acute ischaemic stroke: time for a rethink?Bypass for primary percutaneous intervention or thrombolysis at the nearest hospital for patients suffering ST-elevation myocardial infarctionThrombolysis for acute upper extremity deep vein thrombosisThrombolytic therapy for pulmonary embolismThrombolysis for acute ischaemic strokePre-hospital versus in-hospital thrombolysis for acute myocardial infarctionThrombolysis for acute deep vein thrombosisBypass for primary percutaneous intervention or thrombolysis at the nearest hospital for patients suffering ST-elevation myocardial infarctionSurgery versus thrombolysis for initial management of acute limb ischaemiaThrombolysis (different doses, routes of administration and agents) for acute ischaemic strokePercutaneous vascular interventions versus intravenous thrombolytic treatment for acute ischaemic strokeThrombolytic therapy for pulmonary embolismThrombolysis for acute ischaemic strokeThrombolytic agents for arterial and venous thromboses in neonatesThrombolysis (different doses, routes of administration and agents) for acute ischaemic strokeThrombolytic therapy for pulmonary embolismThrombolysis for acute deep vein thrombosisThrombolysis for cerebral vein and dural sinus thrombosisInfusion techniques for peripheral arterial thrombolysisThrombolysis for acute ischaemic strokePrimary angioplasty versus intravenous thrombolysis for acute myocardial infarctionThrombolytic agents for arterial and venous thromboses in neonatesPrimary angioplasty versus intravenous thrombolysis for acute myocardial infarctionLoss of quality adjusted days as a trial endpoint: effect of early thrombolytic treatment in suspected myocardial infarction. Grampion Region Early Anistreplase Trial (GREAT)Assessment of the practicality and safety of thrombolysis with anistreplase given by general practitioners.Thrombolytic properties and side effects of brinase (fibrinolytic enzyme from Aspergillus oryzae) in the dogThe benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trialMyeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI ...A comparison of aspirin and anticoagulation following thrombolysis for myocardial infarction (the AFTER study): a multicentre unblinded randomised clinical trialMagnitude of benefit from earlier thrombolytic treatment in acute myocardial infarction: new evidence from Grampian region early anistreplase trial (GREAT)Thrombolysis versus primary percutaneous coronary intervention for ST elevation myocardial infarctions at Chilliwack General HospitalDebate: Should the elderly receive thrombolytic therapy or primary angioplasty?Debate: Should the elderly receive thrombolytic therapy, or primary angioplasty, for acute myocardial infarction? The case for primary angioplastyLeft ventricular apical thrombus after systemic thrombolysis with recombinant tissue plasminogen activator in a patient with acute ischemic strokeCatheter-related septic thrombophlebitis of the great central veins successfully treated with low-dose streptokinase thrombolysis and antimicrobials.How can we improve stroke thrombolysis rates? A review of health system factors and approaches associated with thrombolysis administration rates in acute stroke careThrombolysis: A Critical First-Line Therapy with an Unfulfilled Potential
P921
Q21093193-0772F1CE-6582-402B-BB1C-1E1C48BAB2AFQ22252960-4F27A64E-8ABE-4C3C-9E6E-1CF2BF45D210Q22306183-905B1A72-4400-4A13-BB3B-5D959CC9FD47Q22306546-28C4E09A-7606-42B1-A56F-980CD1D77424Q24185840-A734C3C9-B76A-4C08-8060-5463D85B8697Q24185948-4A0C0EE2-EBA7-421A-91DF-B698CA06AF28Q24186934-25772E59-25F0-4F40-9452-637946434105Q24194788-5142F9BC-68F6-4545-93C4-49B9722DFFACQ24197751-FD60864D-A149-4684-BE63-699AF6A06CAAQ24201015-C152B947-C153-46EE-847E-EFAEF87DD7BDQ24201380-1937344D-CBE5-4901-87B5-9FC825DE5275Q24202041-EF16357E-31A7-4EB2-86EC-23BB20F0C715Q24202641-CB16C7E1-9966-4BC2-A39C-1E9383F48F26Q24234840-32D09312-13A7-44B5-89F1-41443EB13D10Q24239835-EF71CCA6-20DA-48E3-BD89-0EAA39EAB036Q24240067-9FD25CB6-EDF6-40B1-A3FA-14C58CAA6B46Q24244848-008812A6-E20D-4822-9634-34A5ADFDDDC1Q24245758-5C771689-186E-4186-802B-09F61329BF47Q24246260-8F3F0065-9650-4A40-9817-BBF10C56D35AQ24246705-4E110B1F-BD7A-4CB8-AB41-3DEDA7B9CFCAQ24247401-45671F6E-28FC-4D81-8F43-23A6EFD0AD8EQ24247401-F3E0B0DA-C1F2-4DAE-8E81-030FB6C11CFAQ24247500-3AFB33B6-655B-439A-A541-95FACE9AB3ADQ24247962-0435F380-0089-4A95-8559-EF0E43736193Q24248081-D6844409-FFFC-4931-BE00-4F206AEFBC36Q24250094-42A82385-62AD-48E1-B469-C01CBD1AFD19Q24250148-FA010D8B-DCD3-4A73-ADA8-6E09ABFED76DQ24519047-A4A21C5E-B967-4B74-B5D2-FE1D1D32893EQ24536312-456D8F4F-FCCA-457B-98F7-A0FB85E5872CQ24564492-CDF76639-88C3-4DA5-9F1F-E56227591C93Q24595579-D884C6C3-A456-4BA1-A4F4-3D0C9611C8A7Q24650933-1321DF7C-1787-4D46-8EA3-8529426B1ACAQ24654982-881F10EF-CFD3-4738-B6E8-E3199A996026Q24655623-F5CDD973-9243-4A13-A611-A0C203733155Q24657444-97C17E1D-2787-4492-911F-EE273EE0178BQ24792815-12B841CD-5136-412A-8B56-74D4C5EFD938Q24792897-9FC699F9-F4AE-403B-9F93-C98491B1D784Q24811278-15C30C0E-A69F-433C-A848-05F6295A12ACQ24817077-C103AE11-2210-4D59-BAAC-13DAE793B625Q26750590-D69F096A-D509-44AD-94BE-3160A4E858BB
P921
description
Auflösung von Blutgerinnseln
@de
breakdown (lysis) of blood clots formed in blood vessels, using medication
@en
farmakologiczne rozpuszczenie zakrzepu w naczyniu krwionośnym
@pl
rottura di trombi, emboli o co ...... emente chiamati «trombolitici»
@it
انحلال الخثره
@ar
name
Tan huyết khối
@vi
Thrombolyse
@de
Thrombolyse
@fr
Trombolisi
@it
Tromboliz
@tr
Tromboliza
@pl
Trombolys
@sv
Trombolyse
@da
Trombolyse
@nb
Trombolyse
@nl
type
label
Tan huyết khối
@vi
Thrombolyse
@de
Thrombolyse
@fr
Trombolisi
@it
Tromboliz
@tr
Tromboliza
@pl
Trombolys
@sv
Trombolyse
@da
Trombolyse
@nb
Trombolyse
@nl
altLabel
Lysetherapie
@de
Thrombolyse
@nl
Thrombolytique
@fr
Thrombolytiques
@fr
thrombolytic therapy
@en
traitement thrombolytique
@fr
Трамбалізіс
@be
Тромбалізіс
@be
Тромболизис
@ru
溶栓藥物
@zh
prefLabel
Tan huyết khối
@vi
Thrombolyse
@de
Thrombolyse
@fr
Trombolisi
@it
Tromboliz
@tr
Tromboliza
@pl
Trombolys
@sv
Trombolyse
@da
Trombolyse
@nb
Trombolyse
@nl
P486
P6366
P646
P672
P279
P3827
thrombolytic-therapy
P486
P5082
trombolyse
P6366
2779581417
P646
P672
E02.319.913